These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 24597459

  • 1. Feasibility of creating a National ALS Registry using administrative data in the United States.
    Kaye WE, Sanchez M, Wu J.
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):433-9. PubMed ID: 24597459
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of amyotrophic lateral sclerosis - United States, 2010-2011.
    Mehta P, Antao V, Kaye W, Sanchez M, Williamson D, Bryan L, Muravov O, Horton K, Division of Toxicology and Human Health Sciences, Agency for Toxic Substances and Disease Registry, Atlanta, Georgia, Centers for Disease Control and Prevention (CDC).
    MMWR Suppl; 2014 Jul 25; 63(7):1-14. PubMed ID: 25054277
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Incidence of amyotrophic lateral sclerosis in the United States, 2014-2016.
    Mehta P, Raymond J, Punjani R, Larson T, Han M, Bove F, Horton DK.
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 Aug 25; 23(5-6):378-382. PubMed ID: 35023792
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of amyotrophic lateral sclerosis (ALS), United States, 2016.
    Mehta P, Raymond J, Punjani R, Larson T, Bove F, Kaye W, Nelson LM, Topol B, Han M, Muravov O, Genson C, Davis B, Hicks T, Horton K.
    Amyotroph Lateral Scler Frontotemporal Degener; 2022 May 25; 23(3-4):220-225. PubMed ID: 34423697
    [Abstract] [Full Text] [Related]

  • 7. Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data.
    Bryan L, Kaye W, Antao V, Mehta P, Muravov O, Horton DK.
    PLoS One; 2016 May 25; 11(4):e0153683. PubMed ID: 27124833
    [Abstract] [Full Text] [Related]

  • 8. Evaluating the completeness of the national ALS registry, United States.
    Kaye WE, Wagner L, Wu R, Mehta P.
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Feb 25; 19(1-2):112-117. PubMed ID: 29020837
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Incidence and prevalence of Amyotrophic Lateral Sclerosis in three Italian Regions: a study based on health administrative databases.
    Bacigalupo I, Finocchietti M, Paoletti O, Bargagli AM, Brunori P, Lombardi N, Sciancalepore F, Agabiti N, Kirchmayer U.
    Epidemiol Prev; 2024 Feb 25; 48(3):201-209. PubMed ID: 38995133
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of the Completeness of ALS Case Ascertainment in the US National ALS Registry: Application of the Capture-Recapture Method.
    Nelson LM, Topol B, Kaye W, Raymond J, Horton DK, Mehta P, Wagner T.
    Neuroepidemiology; 2022 Feb 25; 56(2):104-114. PubMed ID: 34929703
    [Abstract] [Full Text] [Related]

  • 13. Atlanta metropolitan area amyotrophic lateral sclerosis (ALS) surveillance: incidence and prevalence 2009-2011 and survival characteristics through 2015.
    Punjani R, Wagner L, Horton K, Kaye W.
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb 25; 21(1-2):123-130. PubMed ID: 31795746
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preparing for a U.S. National ALS Registry: Lessons from a pilot project in the State of Georgia.
    Benatar M, Wuu J, Usher S, Ward K.
    Amyotroph Lateral Scler; 2011 Mar 25; 12(2):130-5. PubMed ID: 20843169
    [Abstract] [Full Text] [Related]

  • 17. A brief report on juvenile amyotrophic lateral sclerosis cases in the United States National ALS Registry: 2010-2018.
    Raymond J, Berry J, Kasarskis EJ, Larson T, Horton DK, Mehta P.
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 Feb 25; 25(1-2):211-213. PubMed ID: 37789566
    [Abstract] [Full Text] [Related]

  • 18. Amyotrophic lateral sclerosis among patients with a Medicare Advantage prescription drug plan; prevalence, survival and patient characteristics.
    Bhattacharya R, Harvey RA, Abraham K, Rosen J, Mehta P.
    Amyotroph Lateral Scler Frontotemporal Degener; 2019 May 25; 20(3-4):251-259. PubMed ID: 30892090
    [Abstract] [Full Text] [Related]

  • 19. Recruitment of population-based controls for ALS cases from the National ALS Registry.
    Bear TM, Malek AM, Foulds A, Rager J, Deperrior SE, Vena JE, Larson TC, Mehta P, Horton DK, Talbott EO.
    Amyotroph Lateral Scler Frontotemporal Degener; 2021 Aug 25; 22(5-6):395-400. PubMed ID: 33860698
    [Abstract] [Full Text] [Related]

  • 20. Recruitment of Patients With Amyotrophic Lateral Sclerosis for Clinical Trials and Epidemiological Studies: Descriptive Study of the National ALS Registry's Research Notification Mechanism.
    Mehta P, Raymond J, Han MK, Larson T, Berry JD, Paganoni S, Mitsumoto H, Bedlack RS, Horton DK.
    J Med Internet Res; 2021 Dec 07; 23(12):e28021. PubMed ID: 34878988
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.